Recombinant Human Granulocyte/Macrophage Colony-stimulating Factor for Injection (Changchun Institute of Biological Products)

注射用重组人粒细胞巨噬细胞刺激因子 (长春生物制品研究所有限责任公司)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant Human Granulocyte/Macrophage Colony-stimulating Factor for Injection (Changchun Institute of Biological Products)
Drug Alias NameSai Ai Er
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionGranulocyte-macrophage colony-stimulating factor receptor stimulants
TargetsGranulocyte-macrophage colony-stimulating factor receptor
Therapy Area/IndicationsLeukopeniaMyelodysplastic Syndromes
Global Approved IndicationsLeukopeniaMyelodysplastic Syndromes
Approved Indications in ChinaLeukopeniaMyelodysplastic Syndromes
Original Approved Country/TerritoryMainland China
Original Approved Date2000/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChangchun Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChangchun Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsLeukopeniaMyelodysplastic Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeL03AA02
Related LinksN/A